Northfield Laboratories files $100 million securities shelf

By Angela McDaniels

Seattle, Sept. 1 - Northfield Laboratories Inc. registered to sell up to $100 million of securities in an S-3 filing with the Securities and Exchange Commission on Friday.

Covered by the shelf are common stock, preferred stock, depositary shares, stock purchase contracts, debt securities and warrants. Debt securities may be structured as convertibles.

Proceeds will be used for general corporate purposes.

Northfield Laboratories is based in Evanston, Ill., and is developing a hemoglobin-based, oxygen-carrying red blood cell substitute for the treatment of large-volume blood loss.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.